WeVote

Bill

Bill

SB 6220

Concerning high THC cannabis products.

2023-2024 Regular Session Introduced by Jesse Salomon and 3 co-sponsors

Washington bill regulates high-THC cannabis products with new potency standards and safety requirements to address public health and consumer protection concerns.

Executive session scheduled, but no action was taken in the Senate Committee on Ways & Means at 10:00 AM.
0
WeVote Research Nonpartisan
Bill Summary · SB 6220

Legislative bill overview

SB 6220 addresses regulations for high-THC cannabis products in Washington State. The bill has progressed through the Senate Committee on Labor & Commerce with a recommendation for a substituted version to pass, and is currently under consideration in the Ways & Means Committee.

Why is this important

Cannabis regulation directly affects public health, consumer safety, and state tax revenue. High-THC products raise particular concerns about potency labeling, youth access, and health impacts, making regulatory clarity significant for both consumers and the cannabis industry.

Potential points of contention

  • Product potency standards – Disagreement over what constitutes "high THC" and whether limits should be imposed on maximum allowable potency
  • Consumer protection vs. market access – Balancing stricter regulations that protect vulnerable populations against industry concerns about reduced product availability and sales
  • Tax and revenue implications – How regulations affect cannabis tax revenues, which fund education and health programs, versus compliance costs for producers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.